Linzagolix (Yselty) with hormonal add-back therapy will offer a new at-home treatment option for some women in England with ...

Clinical trials have shown linzagolix significantly reduces both menstrual pain and non-menstrual pelvic discomfort compared ...

Linzagolix will only be available for patients whose previous medical or surgical treatments have been unsuccessful.

A new at-home daily pill for endometriosis has been approved for use on the NHS in England. The tablet, called linzagolix but ...

A NEW daily pill to treat ‘debilitating and life-limiting’ endometriosis will be rolled on the NHS after getting the green ...

A new at-home pill for endometriosis has been approved for use on the NHS. The once-a-day tablet, called linzagolix but also ...

The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to ...

Relugolix–estradiol–norethisterone (relugolix combination therapy [CT]; Ryeqo, Gedeon Richter) is indicated 'in adult women of reproductive age for symptomatic treatment of endometriosis in women with ...

Androgen deprivation therapy (ADT) is standard for advanced prostate cancer. Relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, is the only oral ADT, with limited real-world data ...

The provincial government announced the expansion of the Saskatchewan Cancer Agency’s oncology drug formulary in a new release this week, adding the drugs Capivasertib and Relugolix — which are used ...